• Advances and challenges in the treatment of myasthenia gravis 

      Schneider-Gold, Christiane; Gilhus, Nils Erik (Journal article; Peer reviewed, 2021)
      Myasthenia gravis (MG) is a chronic autoimmune disease with fluctuating muscle weakness and fatigability. Standard immunomodulatory treatment may fail to achieve sufficient improvement with minimal symptom expression or ...
    • Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach 

      Woock, Malin; Martinez-Majander, Nicolas; Seiffge, David J.; Selvik, Henriette Aurora; Nordanstig, Annika; Redfors, Petra; Lindgren, Erik; Sanchez van Kammen, Mayte; Rentzos, Alexandros; Coutinho, Jonathan M.; Doyle, Karen; Næss, Halvor; Putaala, Jukka; Jood, Katarina; Tatlisumak, Turgut (Journal article; Peer reviewed, 2022)
      The association between stroke and cancer is well-established. Because of an aging population and longer survival rates, the frequency of synchronous stroke and cancer will become even more common. Different pathophysiologic ...
    • Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden 

      Hakkarainen, Katja Marja; Juuti, Rosa; Burkill, Sarah; Geissbühler, Yvonne; Sabidó, Meritxell; Popescu, Catrinel; Suzart-Woischnik, Kiliana; Hillert, Jan; Artama, Miia; Verkkoniemi-Ahola, Auli; Myhr, Kjell-Morten; Mehtälä, Juha; Bahmanyar, Shahram; Montgomery, Scott; Korhonen, Pasi (Journal article; Peer reviewed, 2020)
      Background Our aim was to estimate and compare the prevalence of adverse pregnancy outcomes among pregnant women with multiple sclerosis (MS) exposed to interferon beta (IFNB) and among women with MS unexposed to any MS ...